Celeste Ewig, PharmD

Graduate Assistant
Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida

Poster(s):

• (096) Medications considered to have substantial teratogenic risk commonly used in US pregnant population – quality of evidence and magnitude of risk
  Sunday, August 27, 2023

  8:00 AM – 1:30 PM ADT

• (136) Secular Trends and Determinants of Hepatitis C Virus Testing during Pregnancy
  Saturday, August 26, 2023

  8:00 AM – 6:00 PM ADT

• (287) Assessing neonatal outcome misclassification using mother-infant dyad claims
  Saturday, August 26, 2023

  8:00 AM – 6:00 PM ADT

• (A22) Utilization of antihypertensives before, during, and after pregnancy
  Friday, August 25, 2023

  8:00 AM – 6:00 PM ADT

• (C26) A Review of Existing Clinical Guideline Recommendations for Contraceptive Selection in Women with Epilepsy with a Focus on Drug-Drug Interactions
  Sunday, August 27, 2023

  8:00 AM – 1:30 PM ADT